In the present study, we observed that miR-2467-3p targets ENO3 expression, inhibits the malignant biological behavior of and glycolysis in colon cancer cells, and alleviates the cancer-promoting effects of LINC00174. Here, ENO3 is linked to colonic neoplasm.